1.Date of the board of directors resolution or date of occurrence of the change: 2022/12/30
2.Position (Please enter chairperson or president/general manager): CEO
3.Name of the previous position holder: Michael Chang
4.Resume of the previous position holder: Chairman of the Board, OBI Pharma Inc.
5.Name of the new position holder: Yun Yen (represent tentatively)
6.Resume of the new position holder: Chairman of the Board, Tanvex BioPharma Inc.
7.Circumstances of change (Please enter ”resignation”, ”dismissal”, ”term expired” , ”job relocation”, ”severance”, ”retirement”, ”death” or ”new appointment”): new appointment
8.Reason for the change: new appointment
9.Effective date of the new appointment: 2022/12/30
10.Any other matters that need to be specified: The former CEO of the Company, Dr. Michael Chang, passed away on 2022/12/29. The Board of Directors resolved today that the duty of CEO will be represent by Dr. Yun Yen, the Chairman of the Board, tentatively with a term of half year. The Company will seek for adequate candidate continuously.
2022.Dec.30
Announcement of change of CEO
1.Date of the board of directors resolution or date of occurrence of the change: 2022/12/30 2.Position (Please enter chairperson or president/general manager): CEO 3.Name of the previous position holder: Michael Chang 4.Resume of the previous position holder: Chairman of the Board, OBI Pharma Inc. 5.Name of the new position holder: Yun Yen (represent tentatively) 6.Resume […]